Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
Melanoma is the most lethal form of skin cancer and surgery remains the preferred and most effective treatment. Nevertheless, there are cases where surgery is not a viable method and alternative treatments are therefore adopted. One such treatment that has been tested is topical 5% imiquimod (IMQ) c...
Saved in:
Main Authors: | Supreeda Tambunlertchai (Author), Sean M. Geary (Author), Aliasger K. Salem (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malignant Melanoma Treated with Topical Imiquimod: A Bespoke Treatment That Spared the Amputation
by: Emanuele Verga, et al.
Published: (2019) -
Melanoma "in situ" tratado con Imiquimod Melanoma in situ treated with Imiquimod
by: RE Achenbach, et al.
Published: (2012) -
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023) -
A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
by: Zhongkun Zhang, et al.
Published: (2021) -
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
by: Silvia Vaienti, et al.
Published: (2023)